Olema Pharmaceuticals, Inc. · NASDAQ:OLMA
Bain Capital Life Sciences Opportunities IV, L.P. reported a 8.15% stake in Olema Pharmaceuticals, Inc. (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 15, 2026
Bain Capital Life Sciences Opportunities IV, L.P. reported a 8.15% stake in Olema Pharmaceuticals, Inc., 7,473,238 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).
- Stake
- 8.15%
- Shares
- 7,473,238
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Bain Capital Life Sciences Opportunities IV, L.P. | 8.15% | 7,473,238 |
Source
Related
- Olema Pharmaceuticals, Inc.
- Bain Capital Life Sciences Opportunities IV, L.P.
- Olema Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · Bain Capital Life Sciences Opportunities IV, L.P. · Feb 17, 2026
- Schedule 13G/A · Bain Capital Life Sciences Opportunities IV, L.P. · May 15, 2025
- Schedule 13G/A · Bain Capital Life Sciences Opportunities IV, L.P. · Jan 13, 2025
- Schedule 13D/A · Bvf Partners L P · Oct 16, 2026
- Schedule 13G/A · FMR LLC · Aug 6, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 29, 2026
- Form 4 · Harmon Cyrus · Jul 27, 2026
- Schedule 13G/A · Janus Henderson Group PLC · May 15, 2026